denotes an abstract that is clinically relevant.
denotes that this is a ticketed session.
Program: ASH-a-Palooza
Friday, December 4, 2020: 10:00 AM-12:00 PM
Moderator:
Disclosures:
No relevant conflicts of interest to declare.
Speakers:
Brad S. Kahl, MD, Washington University School of Medicine in St. Louis
and
Anthony R. Mato, MD, Memorial Sloan Kettering Cancer Center
Disclosures:
Kahl: BeiGene: Consultancy, Membership on an entity's Board of Directors or advisory committees, Research Funding; Janssen: Consultancy, Membership on an entity's Board of Directors or advisory committees; ADC Therapeutics: Consultancy, Membership on an entity's Board of Directors or advisory committees, Research Funding; Acerta: Consultancy, Research Funding; Roche Laboratories Inc: Consultancy; Pharmacyclics LLC: Consultancy; Genentech: Consultancy; Celgene Corporation: Consultancy; AbbVie: Consultancy; AstraZeneca Pharmaceuticals LP: Consultancy, Membership on an entity's Board of Directors or advisory committees.